Navigation Links
Tubing Prep Station, 100-120 V from Bio-Rad

ProductsTubing Prep Station, 100-120 V from Bio-Rad
Company Bio-Rad
Item Tubing Prep Station, 100-120 V
Price 
Description The tubing prep station, 100-120 V, is used to coat the inner wall of tubing with DNA-coated gold particles to create the source of the DNA that enters target cells by helium discharge with the Helios gene gun. The station includes a tubing support cylinder, power cord, O-rings, tubing prep unit, 12 foot Nalgene nitrogen regulator hose, two 0.1875 inch barb-to-male Luer-Lok fittings, nitrogen flowmeter fitting, 2.125 inch barb-to-male Luer-Lok fitting, one 0.078125 Allen wrench, and a 10 ml syringe holder. The dimensions of the station are 85 x 10 cm.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. F10 Tubing Kit from Bio-Rad
2. iEMS Incubator/Shaker 3 module (100-120 V) from Thermo Scientific
3. BioLogic Maximizer Kit, 100-120 V from Bio-Rad
4. Helios Gene Gun System, 100-120 V from Bio-Rad
5. Rotofor Purification System, 100-120 V from Bio-Rad
6. Helios Gene Gun Low-Pressure System, 100-120 V from Bio-Rad
7. Bio-Beads S-X8 Support, 100 g from Bio-Rad
8. UNOsphere S Support, 100 ml from Bio-Rad
9. Organic Acid Analysis Standard, 6 vials from Bio-Rad
10. Carbohydrate Analysis Standard, 6 vials from Bio-Rad
11. iTaq DNA Polymerase, 250 U from Bio-Rad
Human Norrin Biotinylated Affinity Purified PAb Protein Family: Other Growth Factors, Other Wnt-related Molecules
FIA-series XYZ autosampler from Ocean Optics
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers
Request Info
Biology Products:
(Date:5/16/2008)...s of shipments involving regulated radioactive mat...g concern to safety and industry experts. Meeting ... on an action plan for the Mediterranean region th... centres and organizations that rely on timely del...pment issues have surfaced over the past several y...
(Date:5/16/2008)...the Canadian Journal of Forest Research presents t...in one of the first landscape-scale experiments on...ine ecosystems. , The Blacks Mountain Interdisci..., Humboldt State University, Oregon State Universi...life Conservation Society scientists collaborating...
(Date:5/16/2008)...team of experts in biomechanics and physiology fro...the Massachusetts Institute of Technologys Media L...orn by Oscar Pistorius, a 21-year-old South Africa...h an unfair advantage in the 400-meter race. Their...ice University Locomotion Laboratory, under the di...
(Date:5/15/2008)...d global climate change has long been a concern fo...lic policy issue, the problem of excessive reactiv...nd a growing circle of environmental scientists wh...ment and negatively alters local and global ecosys...ew papers by leading environmental scientists brin...
Breaking Biology News(10 mins):Experts tackle shipment issues for beneficial radiation sources 2Experts tackle shipment issues for beneficial radiation sources 3Pioneering landscape-scale research releases first findings 2Breaking news: Study revives Olympic prospects for amputee sprinter 2Breaking news: Study revives Olympic prospects for amputee sprinter 3Addressing the 'nitrogen cascade' 2Addressing the 'nitrogen cascade' 3FDA Approves Expanded Label for FluMist 28R 29 to Include Children Two to Five Years of Age 1568 1FDA Approves Expanded Label for FluMist 28R 29 to Include Children Two to Five Years of Age 1568 2FDA Approves Expanded Label for FluMist 28R 29 to Include Children Two to Five Years of Age 1568 3FDA Approves Expanded Label for FluMist 28R 29 to Include Children Two to Five Years of Age 1568 4FDA Approves Expanded Label for FluMist 28R 29 to Include Children Two to Five Years of Age 1568 5Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital 684 1Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital 684 2Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital 684 3Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital 684 4Ardea Biosciences Inc Presents Results of Phase 1 Studies of RDEA806 a Novel NNRTI for HIV at 47th ICAAC 319 1Ardea Biosciences Inc Presents Results of Phase 1 Studies of RDEA806 a Novel NNRTI for HIV at 47th ICAAC 319 2Ardea Biosciences Inc Presents Results of Phase 1 Studies of RDEA806 a Novel NNRTI for HIV at 47th ICAAC 319 3Ardea Biosciences Inc Presents Results of Phase 1 Studies of RDEA806 a Novel NNRTI for HIV at 47th ICAAC 319 4ESMO Oxford Journals and the Japanese Society of Medical Oncology announce collaboration 1567 1ESMO Oxford Journals and the Japanese Society of Medical Oncology announce collaboration 1567 2
...trial of a DNA vaccine designed to prevent H5N1 av..., when the vaccine was administered to the first v...) Clinical Center in Bethesda, MD. Scientists from... Institute of Allergy and Infectious Diseases (NIA...ne. The vaccine does not contain any infectious ma...
...acteria can complicate treatment after many surgic...t Staphylococcus aureus (MRSA), which has been fou...ost-operative complication. In a study published i...almology, researchers found MRSA infections in the...hese are the first cases of MRSA infectious kerati...
...mpt to establish a herd of mouflon for sport hunti... ago has inadvertently created a laboratory for ge...y. , A mouflon population, bred over dozens of gen...lanted to Haute Island from a Parisian zoo, has ma...ents. This finding challenges the widely accepted ...
...ple die every year from respiratory diseases such ...ar, an infection can be dangerous. What is more, t...group as it is with younger people. The reason for...e system is reduced. Why this is the case is large... University of Bonn is now starting which aims at ...
Other Biology News:NIAID DNA vaccine for H5N1 avian influenza enters human trial 2NIAID DNA vaccine for H5N1 avian influenza enters human trial 3Drug-resistant bacterial infections serious complication after corrective eye surgery 2Remote sheep population resists genetic drift 2Fighting influenza & co. with 40,000 blood samples 2Fighting influenza & co. with 40,000 blood samples 3
(Date:5/16/2008)...ang of Children,s Hospital of, Philadelphia will ...May 21st, WELLES..., a pioneer in,the development of cost-effective, ...unced that the company will feature its Ziplex Aut...ongress, booth 16. Currently,available for researc...
(Date:5/16/2008)...aTag(TM) technology,s ability to ...NCISCO, Calif., May 16 /- M...nnounced that scientific,collaborators will presen...logy assay, as a means to measure HER2 and predict...s with metastatic breast cancer at the,upcoming 44...
(Date:5/16/2008)...ner Aqua Bounty to scale back commitment to... TSX symbol: SBS, CALGARY, May...c.,(TSX:SBS), a biotechnology company developing a...nd cardiovascular diseases, today announced that,i...M) shrimp feed additive,program, Aqua Bounty Techn...
(Date:5/16/2008)...Therapeutics Corporation,announced today that it h...twelve-week Phase IIb trial with oral larazotide a...tion, for the treatment of patients with active,ce...ized, double-blind,placebo-controlled study will ...afety and tolerability of larazotide acetate in 10...
Breaking Biology Technology:Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16 2Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 2Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 3Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 4Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 5SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 2SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 3Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3
... animal sciences professor at the University of Wi... out to several businesses, only to sit on the she...iotechnology that was was not being promoted by an...through the Wisconsin Alumni Research Foundation. ...ce about 1994 or 95," Cook said. "No one was movin...
...ct experience with really bad technology. Technol...chnology that confuses, yes, but really, really ba...intos or more recently SUV-flipping Firestone tire...agic technology badness that sneaks up on us. Wer... a niche in the market, with supportive customers,...
...h and Bill Clinton urge Americans to come to aid o...appeal comes from two former presidents, but becau...-relief has dawned. , ,Bush and Clinton point view...which is helping to coordinate the millions of dol... the world learned of the tragedy in Southeast Asi...
...nnounced Wisconsins next energy move would be away...els Initiative. The initiative opens up funding to...rn, and research where they would be most effectiv...t we have the corn for ethanol, Doyle said in a st... have ingenuity. , ,According to gubernatorial spo...
Other Biology Technology:Scientist takes back patents and develops product others ignored 2Scientist takes back patents and develops product others ignored 3Why bad technology happens to good organizations 2Why bad technology happens to good organizations 3Outpouring of tsunami relief displays power of the Internet 2Outpouring of tsunami relief displays power of the Internet 3Governor wants $2 million for biofuels in budget 2